FDA Drug Application (021884) for IPLEX by INSMED

Back to FDA Applications sponsored by INSMED

Application Number021884
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage36MG/0.6ML
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameIPLEX
Active IngredientMECASERMIN RINFABATE RECOMBINANT



Back to FDA Applications sponsored by INSMED